Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.360
+0.140 (3.32%)
At close: Mar 9, 2026, 4:00 PM EDT
4.510
+0.150 (3.44%)
After-hours: Mar 9, 2026, 7:35 PM EDT

Cytek Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-66.54-6.02-12.152.483.03
Depreciation & Amortization
11.9810.499.235.661.24
Stock-Based Compensation
24.5926.8522.0516.66.59
Other Adjustments
30.09-13.65-3.342.962.42
Change in Receivables
0.37-5.43-7.33-19.74-12.37
Changes in Inventories
-5.2414.764.29-17.65-7.07
Changes in Accounts Payable
0.452.58-1.781.86-0.26
Changes in Accrued Expenses
3.97-0.820.737.4710.98
Changes in Unearned Revenue
3.63.746.529.4110.01
Changes in Other Operating Activities
-6.99-6.22-14.77-21.27-9.95
Operating Cash Flow
-4.6925.385.28-12.234.63
Operating Cash Flow Growth
-380.57%---69.45%
Capital Expenditures
-4.08-3.53-4.65-9.75-4.36
Sale of Property, Plant & Equipment
0.250.29---
Purchases of Intangible Assets
-0.11-0.2-0.18-0.12-
Purchases of Investments
-278.16-274.06-175.94-46.04-
Proceeds from Sale of Investments
292.21195132--
Payments for Business Acquisitions
--0.47-45.13--16.63
Investing Cash Flow
10.12-82.97-93.89-55.91-20.99
Short-Term Debt Issued
5.584.18---
Short-Term Debt Repaid
-----2.77
Net Short-Term Debt Issued (Repaid)
5.584.18---2.77
Long-Term Debt Issued
---2.98-
Long-Term Debt Repaid
-4.75-0.56-0.57-0.05-
Net Long-Term Debt Issued (Repaid)
-4.75-0.56-0.572.93-
Issuance of Common Stock
1.472.723.322.79216.33
Repurchase of Common Stock
-15.07-21.61-44.15--
Net Common Stock Issued (Repurchased)
-13.6-18.89-40.832.79216.33
Other Financing Activities
-0.67-0.55-0.42-0.21-
Financing Cash Flow
-13.43-15.82-41.815.51213.56
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.114.53-1.45-2.491.3
Net Cash Flow
-7.89-68.89-131.87-65.12198.5
Free Cash Flow
-8.7721.850.63-21.980.27
Free Cash Flow Growth
-3352.45%---98.05%
FCF Margin
-4.35%10.90%0.33%-13.40%0.21%
Free Cash Flow Per Share
-0.070.170.00-0.160.00
Levered Free Cash Flow
-62.0318.6-13.15-18.763.88
Unlevered Free Cash Flow
-86.37-0.68-21.97-27.835.27
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q